1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Metastatic Uveal Melanoma Global Clinical Trials Review, H1, 2014

Metastatic Uveal Melanoma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Metastatic Uveal Melanoma Global Clinical Trials Review, H1, 2014" provides data on the Metastatic Uveal Melanoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Uveal Melanoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Uveal Melanoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Metastatic Uveal Melanoma Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Metastatic Uveal Melanoma 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Metastatic Uveal Melanoma to Oncology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Unaccomplished Trials of Metastatic Uveal Melanoma 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in Metastatic Uveal Melanoma Therapeutics Clinical Trials 23
Prominent Drugs 24
Latest Clinical Trials News on Metastatic Uveal Melanoma 25
Jun 01, 2013: AstraZeneca's New Therapy Selumetinib Improves Progression-Free Survival And Shrink Tumors In Metastatic Uveal Melanoma, Researchers Report 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Novartis AG 26
Clinical Trial Overview of Novartis AG 26
AstraZeneca PLC 27
Clinical Trial Overview of AstraZeneca PLC 27
GlaxoSmithKline plc 28
Clinical Trial Overview of GlaxoSmithKline plc 28
Spectrum Pharmaceuticals, Inc. 29
Clinical Trial Overview of Spectrum Pharmaceuticals, Inc. 29
Clinical Trial Overview of Top Institutes / Government 30
National Cancer Institute 30
Clinical Trial Overview of National Cancer Institute 30
The Clatterbridge Cancer Centre NHS Foundation Trust 31
Clinical Trial Overview of The Clatterbridge Cancer Centre NHS Foundation Trust 31
The University of Texas M. D. Anderson Cancer Center 32
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 32
Alberta Health Services 33
Clinical Trial Overview of Alberta Health Services 33
Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital 34
Clinical Trial Overview of Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital 34
Memorial Sloan Kettering Cancer Center 35
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 35
Ludwig-Maximilians-Universitat Munich 36
Clinical Trial Overview of Ludwig-Maximilians-Universitat Munich 36
University Hospital, Essen 37
Clinical Trial Overview of University Hospital, Essen 37
Barnes Retina Institute 38
Clinical Trial Overview of Barnes Retina Institute 38
University of California, Los Angeles 39
Clinical Trial Overview of University of California, Los Angeles 39
Five Key Clinical Profiles 40
Appendix 92
Abbreviations 92
Definitions 92
Research Methodology 93
Secondary Research 93
About GlobalData 94
Contact Us 94
Disclaimer 94
Source 95

List of Tables
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials by Region, 2014* 6
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Metastatic Uveal Melanoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Metastatic Uveal Melanoma to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Metastatic Uveal Melanoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Metastatic Uveal Melanoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials by Phase, 2014* 16
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Metastatic Uveal Melanoma Therapeutics, Global, Withdrawn Clinical Trials, 2014* 19
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Metastatic Uveal Melanoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 21
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 26
Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 27
Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 28
Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Spectrum Pharmaceuticals, Inc., 2014* 29
Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 30
Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The Clatterbridge Cancer Centre NHS Foundation Trust, 2014* 31
Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 32
Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Health Services, 2014* 33
Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, 2014* 34
Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 35
Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ludwig-Maximilians-Universitat Munich, 2014* 36
Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Essen, 2014* 37
Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Barnes Retina Institute, 2014* 38
Metastatic Uveal Melanoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014* 39

List of Figures
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Metastatic Uveal Melanoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Metastatic Uveal Melanoma to Oncology Clinical Trials, G7 Countries (%), 2014* 13
Metastatic Uveal Melanoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Metastatic Uveal Melanoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 17
Metastatic Uveal Melanoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Metastatic Uveal Melanoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 21
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23
Metastatic Uveal Melanoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
GlobalData Methodology 93

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.